Name
OÜ MediArte
Registry code
12709264
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
26.08.2014 (10)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
86221 - Provision of specialised medical treatment
144 872 €
-390 €
-0%
833 €
(estimate is approximate)
10 221 €
4
Submitted
No tax arrears
-4%
-3%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Tatiana Zheleznova 29.07.1955 (69) | 100% - 2 500.00 EUR | Board member | Direct ownership | |
| Sergey Saadi 14.06.1986 (38) | - | Board member | - | Founder |
| 2019 05.03.2020 | 2020 28.03.2021 | 2021 17.02.2022 | 2022 03.05.2023 | 2023 31.05.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 33 653 € | 20 296 € | 13 205 € | 39 857 € | 144 872 € |
| Net profit (loss) for the period | 1 124 € | 3 056 € | 6 101 € | -433 € | -390 € |
| Profit Margin | 3% | 15% | 46% | -1% | -0% |
| Current Assets | 9 427 € | 12 866 € | 9 667 € | 11 198 € | 9 153 € |
| Fixed Assets | 438 € | 55 € | 1 377 € | 4 171 € | 4 643 € |
| Total Assets | 9 865 € | 12 921 € | 11 044 € | 15 369 € | 13 796 € |
| Current Liabilities | 1 102 € | 1 102 € | 0 € | 4 758 € | 3 575 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 8 763 € | 11 819 € | 11 044 € | 10 611 € | 10 221 € |
| Employees | 1 | 1 | 1 | 1 | 4 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 5 629.52 € | 5 890.44 € | 4 |
| 2023 Q4 | - | 5 606.31 € | 5 870.05 € | 5 |
| 2023 Q3 | - | 5 792.49 € | 6 065.41 € | 3 |
| 2023 Q2 | - | 4 834.94 € | 5 061.02 € | 3 |
| 2023 Q1 | - | 2 142.46 € | 2 239.03 € | 1 |
| 2022 Q4 | - | 334.6 € | 349.84 € | 1 |
| 2022 Q3 | - | - | - | 1 |
| 2022 Q2 | 6 709.22 € | 382.99 € | - | 1 |
| 2022 Q1 | 725.85 € | - | - | - |
| 2021 Q4 | - | - | - | - |
| 2021 Q2 | - | 1 389.38 € | 670.81 € | - |
| 2021 Q1 | - | 2 169.3 € | 2 351.88 € | 1 |
| 2020 Q4 | - | 1 016.85 € | 1 102.43 € | 1 |
| 2020 Q3 | - | 881.27 € | 955.44 € | 1 |
| 2020 Q2 | - | 1 355.8 € | 1 469.91 € | 1 |
| 2020 Q1 | - | 3 050.58 € | 3 307.32 € | 1 |
